Search results
BioNTech SE (NASDAQ:BNTX) Receives $111.70 Average Target Price from Analysts
ETF DAILY NEWS· 1 day agoShares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been given an average rating of “Hold” by the ten ratings firms that are currently covering the firm, MarketBeat.com ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 4 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
Clinical Trials Arena via Yahoo Finance· 6 days agoGenmab and BioNTech announced the initial data from the phase II GCT1046-04 trial, which evaluated...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 4 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 4 days agoCOVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 5 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 1 day agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...